Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Coherus BioSciences Stock (NASDAQ:CHRS), Quotes and News Summary
Coherus BioSciences Stock (NASDAQ: CHRS) stock price, news, charts, stock research, profile.
| Day Range8.160 - 8.450 | 52 Wk Range5.581 - 14.110 | Open / Close8.410 / 8.420 | Float / Outstanding61.490M / 77.778M |
| Vol / Avg.588.065K / 1.270M | Mkt Cap654.890M | P/E- | 50d Avg. Price7.990 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float61.490M | EPS-3.590 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-05-04 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.690 | (EXPECTED) 2023-02-21 | |||||
| REV | 48.380M | ||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Coherus BioSciences (CHRS) stock?
You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.
Who are Coherus BioSciences's (CHRS) competitors?
Other companies in Coherus BioSciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 4D Molecular Therapeutics (NASDAQ:FDMT), bluebird bio (NASDAQ:BLUE), Immatics (NASDAQ:IMTX) and Fate Therapeutics (NASDAQ:FATE).
What is the target price for Coherus BioSciences (CHRS) stock?
The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by Mizuho on Wednesday, November 16, 2022. The analyst firm set a price target for 21.00 expecting CHRS to rise to within 12 months (a possible 149.41% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Coherus BioSciences (CHRS)?
The stock price for Coherus BioSciences (NASDAQ: CHRS) is $8.42 last updated February 7, 2023 at 9:00 PM UTC.
Does Coherus BioSciences (CHRS) pay a dividend?
There are no upcoming dividends for Coherus BioSciences.
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences’s Q1 earnings are confirmed for Thursday, May 4, 2023.
Is Coherus BioSciences (CHRS) going to split?
There is no upcoming split for Coherus BioSciences.
What sector and industry does Coherus BioSciences (CHRS) operate in?
Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.